Abstract 12826: Genetic Variation in SLC5A2 Mimicking SGLT2-Inhibition Lowers Risk of Cardiovascular Disease and All-Cause Mortality

Background: Treatment with sodium-glucose co-transporter 2 (SGLT2)-inhibitors reduces risk of hospitalization for heart failure and all-cause mortality, but the mechanisms are unclear. Hypothesis: ...